Think of Quinn Healy as her goalkeepers’ bodyguard.

Data support planned dosing regimen and protocol for FIH study to initiate in mid-2025LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Axovia Therapeutics Ltd., a biotechnology company developing therapies to ...

New Drug Application (NDA) for hyperphosphatemia in chronic kidney disease patients on dialysis under review by FDA with PDUFA target action date of June 28, 2025; ongoing ...

Mayor Mike Duggan is preparing to leave office after 11 years at the end of 2025. The city’s next leader will inherit not only a revitalizing downtown but also neighborhoods like Belmont, ...

ROCKVILLE, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in ...

Panelists discuss how polycythemia vera treatment follows a risk-stratified approach, with all patients receiving daily aspirin and phlebotomies to maintain hematocrit below 45%, while high-risk ...

The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 28, 2025, for OLC. Unicycive continues to ...

Moi, E.J. (2025) Empowering Organized Grassroots Women as a Social Change Agent for Sustainability in Kenya. Open Journal of Social Sciences, 13, 18-31. doi: 10.4236/jss.2025.135002 .

BofA Securities Health Care Conference May 13, 2025 2:20 PM ET. Company Participants. Johanna Mercier – Chief Commercial Officer. Conference ...

Beginning on April 7, 2025, the National Association of Attorneys General (NAAG) held its three-day Symposium in Nashville, Tennessee. Throughout ...

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...

Gastric cancer, the fifth most common malignancy worldwide and the fifth most common cause of cancer-related death, is ...